Sophia Genetics Executives Sell 5,600+ Shares via 10b5‑1 Plans, Indicating Routine Portfolio Rebalancing Amid Strong Growth Outlook
Insider sales at Sophia Genetics show routine RSU liquidation, not a decline in confidence; executives use Rule 10b5‑1 plans while the company’s cloud‑diagnostics growth remains strong.
3 minutes to read